Curis News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.08.18	EARNINGS SUMMARY: Details of Curis Inc Q2 Earnings Report (RTTNews)
02.08.18	MOH Boosts Outlook, NBIX Hits All-time High, ACER To Submit Its First NDA In Q4 (RTTNews)
01.06.18	NASH Data Drives MDGL To The Moon, VKTX Turns Head, FDA Nod For KTOV (RTTNews)
31.05.18	/C O R R E C T I O N -- Curis, Inc./ (PR Newswire)
31.05.18	Curis Announces FDA Fast Track Designation for Fimepinostat (CUDC-907) Development in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (PR Newswire)
29.05.18	Curis Announces Effectiveness of 1-for-5 Reverse Stock Split (PR Newswire)
24.05.18	Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development (PR Newswire)
22.05.18	Curis Announces 1-for-5 Reverse Stock Split (PR Newswire)
03.05.18	EARNINGS SUMMARY: Details of Curis Inc Q1 Earnings Report (RTTNews)
03.05.18	Curis Reports First Quarter 2018 Financial Results (PR Newswire)
26.04.18	Curis to Release First Quarter 2018 Financial Results and Hold Conference Call on May 3, 2018 (PR Newswire)
06.04.18	Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
08.03.18	EARNINGS SUMMARY: Details of Curis Inc Q4 Earnings Report (RTTNews)
08.03.18	Curis Reports Fourth Quarter and Year-End 2017 Financial Results (PR Newswire)
05.03.18	Curis to Present at Cowen & Company 38th Annual Health Care Conference (PR Newswire)
01.03.18	/C O R R E C T I O N -- Curis, Inc./ (PR Newswire)
01.03.18	Curis to Release Fourth Quarter and Year-End 2017 Financial Results and Hold Conference Call on March 8, 2018 (PR Newswire)
17.01.18	Curis Begins Phase 1 Trial Of CA-4948 In Patients With Lymphomas - Quick Facts (RTTNews)
17.01.18	Curis Announces Initiation of Phase 1 Trial of CA-4948, a Small Molecule Inhibitor of IRAK4 Kinase in Patients with Lymphoma (PR Newswire)
07.11.17	EARNINGS SUMMARY: Details of Curis Inc Q3 Earnings Report (RTTNews)
13.09.17	Stocks Under Scanner in the Biotech Space -- Curis, Egalet, and Esperion Therapeutics (PR Newswire)
03.08.17	EARNINGS SUMMARY: Details of Curis Inc Q2 Earnings Report (RTTNews)
12.07.17	Technical Insights on Biotech Stocks -- Curis, OvaScience, Regulus Therapeutics, and Vanda Pharma (PR Newswire)
30.05.17	Research Reports Initiation on Biotech Stocks -- Corcept Therapeutics, Curis, OvaScience, and Vanda Pharma (PR Newswire)
04.05.17	Curis Chairman James McNab Jr. To Retire, Martyn Greenacre Named Successor (RTTNews)
04.05.17	EARNINGS SUMMARY: Details of Curis Inc Q1 Earnings Report (RTTNews)
10.03.17	Gainers & Losers Of Mar.9: CBAY, IMMU, TGTX, NSPR, TNDM... (RTTNews)
09.03.17	Research Reports Initiation on Biotech Stocks -- Alnylam Pharma, INSYS Therapeutics, Curis, and GenVec (PR Newswire)
09.03.17	Curis Enters Into $45 Mln Debt Transaction With HealthCare Royalty - Quick Facts (RTTNews)
09.03.17	EARNINGS SUMMARY: Details of Curis Inc Q4 Earnings Report (RTTNews)
12.01.17	Technical Reports on Biotech Stocks -- Halozyme Therapeutics, Keryx Biopharma, Curis, and Agios Pharma (PR Newswire)
21.12.16	Biotech Stocks Head Into 2017 With Clinical Developments That Could Lead to Growth and Added Value (PR Newswire)
03.11.16	EARNINGS SUMMARY: Details of Curis Inc Q3 Earnings Report (RTTNews)
04.08.16	EARNINGS SUMMARY: Details of Curis Inc Q2 Earnings Report (RTTNews)
21.06.16	Curis Announces Dosing Of First Patient In Phase 1 Trial Of CA-170 (RTTNews)
01.06.16	Curis Announces FDA Acceptance Of Investigational NDA For CA-170 (RTTNews)
09.05.16	EARNINGS SUMMARY: Details of Curis Inc Q1 Earnings Report (RTTNews)
04.04.16	Curis Says CUDC - 907 Trial Records Complete Resonse In Large B-cell Lymphoma (RTTNews)
02.03.16	Arsanis Names Michael Gray CFO, Chief Business Officer (RTTNews)
29.02.16	EARNINGS SUMMARY: Details of Curis Inc Q4 Earnings Report (RTTNews)
06.12.15	Curis Reports Clinical Activity Of CUDC-907 (RTTNews)
09.11.15	EARNINGS SUMMARY: Details of Curis Inc Q3 Earnings Report (RTTNews)
08.11.15	Aurigene Presents Data From Oral Small Molecule PD-L1/VISTA And IRAK4 Programs (RTTNews)
19.10.15	Curis Announces Expansion Of Pipeline With Addition Of Two Programs (RTTNews)
06.08.15	Curis Q2 Loss Widens - Quick Facts (RTTNews)
06.08.15	EARNINGS SUMMARY: Details of Curis Inc Q2 Earnings Report (RTTNews)
31.05.15	Curis: CUDC-907 Shows Evidence Of Clinical Activity With Objective Responses (RTTNews)
18.04.15	Aurigene & Curis To Present Data From IRAK-4 Inhibitor Program - Quick Facts (RTTNews)
06.04.15	Curis: FDA Grants Orphan Drug Designation To CUDC-907 - Quick Facts (RTTNews)
21.01.15	Curis And Aurigene Announce Collaboration Agreement - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Curis, Inc.

Aktien Top/Flop

Meistgelesene Nachrichten